Content Validation of a Questionnaire on Sports Activities in Children With Limb Amputation (VESAQ)
Content Validation of the VESAQ Questionnaire on Sports Activities in Children With Limb Amputation Using a Delphi Method
The VESAQ study aims to validate the content of a questionnaire designed to assess sports participation in children with limb amputation. Content validation was conducted using a three-round Delphi method involving a multidisciplinary panel of adult experts with professional or experiential expertise relevant to pediatric limb amputation, rehabilitation, prosthetic management, and adapted physical activity.
Children with limb amputation are the future target population of the questionnaire but did not participate in this content-validation study, and no individual medical data from pediatric patients were collected.
The Delphi process aimed to establish expert consensus on the relevance and clarity of the questionnaire content and to produce a final consensual version of the VESAQ.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The VESAQ (Questionnaire on Sports Activities in Children With Limb Amputation) was developed to provide a structured and multidimensional tool for assessing sports participation in children with limb amputation. The questionnaire addresses dimensions related to limb amputation, prosthetic devices when applicable, sports participation, functional limitations, barriers and facilitators, family, school and sports environments, the child's experience, and the support provided.
Content validation was conducted using a three-round Delphi process involving a multidisciplinary panel of adult experts with relevant professional or experiential expertise in the field of pediatric limb amputation, rehabilitation, prosthetic management, and adapted physical activity.
During the successive Delphi rounds, participants assessed proposed domains and questionnaire items using Likert scales and could provide qualitative comments and suggestions for reformulation. Following each round, responses were analyzed and the questionnaire was progressively revised to improve the clarity, relevance, and organization of its items.
Consensus was predefined as a median score of at least 4, an interquartile range of 1 or less, and an agreement rate of at least 70%. The first Delphi round focused on the main questionnaire domains, the second round evaluated the proposed items in greater detail, and the third round aimed to stabilize consensus and finalize the questionnaire.
A total of 26 experts were included in the study, of whom 23 participated through the end of the third Delphi round. Children with limb amputation did not participate in this content-validation study, and no individual medical data from pediatric patients were collected.
The objective of the study is to establish a final consensual version of the VESAQ based on the Delphi results. This content-validation phase is intended as a methodological step before subsequent studies evaluating the psychometric properties of the questionnaire, including its validity, reliability, reproducibility, and responsiveness to change.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Demande
-
Saint-Maurice, Demande, France, 94410
- Hôpitaux Paris Est Val-de-Marne - Centre de Référence des Malformations des Membres
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthcare professionals or other specialists involved in the care or support of children with limb amputation, including physical and rehabilitation medicine physicians, physiotherapists, prosthetists and orthotists, occupational therapists, adapted physical activity professionals, and sports educators.
- Patient experts.
- At least one year of experience in the field of pediatrics, limb amputation, and/or prosthetic management.
- Willingness to participate in the Delphi process and to provide informed consent and agree to confidentiality requirements
Exclusion Criteria:
- Refusal or withdrawal of consent for the use of study data.
- Non-participation in the Delphi rounds or prolonged disengagement from the Delphi process.
- Conflict of interest related to the validation of the questionnaire, including authorship of the VESAQ or commercial involvement.
- Minors.
- Individuals under legal protection or unable to provide informed consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Multidisciplinary Expert Panel
Adult experts with professional or experiential expertise relevant to pediatric limb amputation, rehabilitation, prosthetic management, and adapted physical activity participated in a three-round Delphi process to assess the relevance and clarity of the VESAQ questionnaire content and establish expert consensus.
|
Participants completed three successive Delphi rounds to evaluate the domains and items of the VESAQ questionnaire.
Items were rated using Likert scales for relevance and clarity, with the possibility of providing qualitative comments and suggestions for reformulation.
After each round, responses were analyzed using predefined consensus criteria, and the questionnaire was progressively revised.
Consensus was defined as a median score of at least 4, an interquartile range of 1 or less, and an agreement rate of at least 70%.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expert Consensus on VESAQ Questionnaire Items
Time Frame: Through completion of the three-round Delphi process, approximately 7 months
|
Expert consensus on the content of the VESAQ questionnaire, assessed using Likert-scale ratings.
Consensus for an item was defined as a median rating of at least 4, an interquartile range of 1 or less, and an agreement rate of at least 70%, with agreement defined as the proportion of ratings of 4 or higher.
|
Through completion of the three-round Delphi process, approximately 7 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Romane RP PIAUD, Institut Merle d'Aubigné
- Study Chair: Mathilde MC CARET, Hôpitaux Paris Est Val-de-Marne (HPEVM)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VESAQ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.